Control of Therapy of Acne Papulopustulosa by Visible Light With Waterfiltered Infrared and / or Adapalen (Differin Gel)

Status

UNKNOWN

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00237978

Enrollment

Registered

2005-10-13

Start date

2006-09-30

Completion date

2009-09-30

Last updated

2009-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne Papulopustulosa

Brief summary

The aim of the study is to investigate the effectivity of visible light in combination with waterfiltered infrared in treating acne papulopustulosa. The reduction of inflammatory and non-inflammatory lesions within 8 weeks will be measured and compared with the standard treatment with Adapalene.

Interventions

DRUGAdapalen

RADIATIONVIS and wIRA

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

14 Years to No maximum

Healthy volunteers

Inclusion criteria

* Mild to moderate acne papulopustulosa according to Burton Scale Stage 3 to 4 * At least 5 inflammatory and 5 non-inflammatory lesions in the face * Age \>= 14 years

Exclusion criteria

* pregnant and nursing women * Antiandrogen therapy * therapy with antibiotics within the last 4 weeks * therapy with retinoids within the last 6 months * natural or artificial UV-therapy within the last 4 weeks * severe acne papulopustulosa according to Burton Scale 5 or 6 * Severe systemic condition * Secondary acne

Design outcomes

Primary

Measure	Time frame
reduction of inflammatory and non-inflammatory lesions within 8 weeks after start of therapy	—

Countries

Germany

Contacts

Primary ContactRoland Aschoff, MD

Roland.Aschoff@mailbox.tu-dresden.de0049-351-458

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026